Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
OTCQB

ECHQFECHOIQ LTD.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About ECHOIQ LTD. (ECHQF)

ECHOIQ LTD. (ECHQF) is a N/A company headquartered in Sydney, NSW, Australia whose shares trade over-the-counter on the OTCQB tier.

Echo IQ Limited provides an artificial intelligence (AI) diagnostics tool, EchoSolv, that enhances the diagnosis of structural heart disease. The Echo IQ platform applies innovative methodologies and a proprietary algorithm to produce risk assessments for patients using their electrocardiographic measurements.

Products and services

The company provides an artificial intelligence diagnostics tool that enhances the diagnosis of structural heart disease.

ECHQF key facts

Ticker symbol
ECHQF
Market tier
OTCQB
Headquarters
Sydney, NSW, Australia
Country of incorporation
AU
Year of incorporation
2010
Employees
6
Estimated market cap
$134.77M (as of May 9, 2025)
Shares outstanding
588,521,043
Reporting standard
International Reporting: ASX - Australian Securities Exchange
Audit status
Audited
Fiscal year end
6/30
Latest filing
Quarterly Report (Mar 31, 2025)

ECHOIQ LTD. leadership

  • Dustin Haines — CEO
  • Samuel Dribin — CTO
  • Deon Strydom — Chief Commercial Officer
  • David Batista — Consultant
  • Jessamyn Sarah Lyons — Company Secretary

Explore more: OTCQB stocks · OTC stocks starting with E

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for ECHOIQ LTD. (ECHQF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Popular OTC Companies to Explore

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Fax
Not provided
Investor Relations Email
Not provided
Headquarters Address
477 Pitt Street Suite 2.114
Sydney, NSW, 2000
Australia

Company Leadership

Chief Executive Officer

C
CEO Information Not Available
Chief Executive Officer

Company Officers

Dustin Haines
CEO
Samuel Dribin
CTO
Deon Strydom
Chief Commercial Officer
David Batista
Consultant
Jessamyn Sarah Lyons
Company Secretary

Social Media

Business Details

Stock Details

Loading modules...